Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients

Clinical trial NCT03324945 · COMPLETED

Trial details

NCT number: NCT03324945
Sponsor: Rachel Miller
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chemotherapy-induced Cognitive Impairment

Start date: 2016-08-01
Primary completion: 2018-10-12
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.